Patents by Inventor Stas FEDECHKIN

Stas FEDECHKIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION
    Publication number: 20240150414
    Abstract: X-ray crystallography has defined conformational properties of a key functional region of the G protein of respiratory syncytial virus (RSV). Mimics of these epitopes have utility as immunogens, as tools for discovery of antibodies and other monoclonal binding agents, and as pharmacological agents to modulate activity of the host receptors for this viral protein.
    Type: Application
    Filed: August 19, 2023
    Publication date: May 9, 2024
    Applicants: Trellis Bioscience, Inc., The Regents of the University of California
    Inventors: Rebecca DUBOIS, Stas FEDECHKIN, Lawrence M. KAUVAR
  • Conformational epitopes in respiratory syncytial virus G protein central conserved region
    Patent number: 11773143
    Abstract: X-ray crystallography has defined conformational properties of a key functional region of the G protein of respiratory syncytial virus (RSV). Mimics of these epitopes have utility as immunogens, as tools for discovery of antibodies and other monoclonal binding agents, and as pharmacological agents to modulate activity of the host receptors for this viral protein.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: October 3, 2023
    Assignees: Trellis Bioscience, LLC, The Regents of the University of California
    Inventors: Rebecca Dubois, Stas Fedechkin, Lawrence M. Kauvar
  • CONFORMATIONAL EPITOPES IN RESPIRATORY SYNCYTIAL VIRUS G PROTEIN CENTRAL CONSERVED REGION
    Publication number: 20190135876
    Abstract: X-ray crystallography has defined conformational properties of a key functional region of the G protein of respiratory syncytial virus (RSV). Mimics of these epitopes have utility as immunogens, as tools for discovery of antibodies and other monoclonal binding agents, and as pharmacological agents to modulate activity of the host receptors for this viral protein.
    Type: Application
    Filed: October 12, 2018
    Publication date: May 9, 2019
    Applicants: Trellis Bioscience, LLC, The Regents of the University of California
    Inventors: Rebecca DUBOIS, Stas FEDECHKIN, Lawrence M. KAUVAR